Jun-Xian Du

681 total citations · 1 hit paper
22 papers, 420 citations indexed

About

Jun-Xian Du is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun-Xian Du has authored 22 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun-Xian Du's work include RNA modifications and cancer (9 papers), RNA Research and Splicing (5 papers) and Epigenetics and DNA Methylation (4 papers). Jun-Xian Du is often cited by papers focused on RNA modifications and cancer (9 papers), RNA Research and Splicing (5 papers) and Epigenetics and DNA Methylation (4 papers). Jun-Xian Du collaborates with scholars based in China, Ethiopia and India. Jun-Xian Du's co-authors include Wei Zhu, Yonglei Liu, Gui‐Qi Zhu, Jialiang Cai, Yihong Luo, Shiping Chen, Zhi Dai, Zhihui Min, Yanxia Zhan and Li Ma and has published in prestigious journals such as Oncogene, Gene and Advanced Science.

In The Last Decade

Jun-Xian Du

20 papers receiving 418 citations

Hit Papers

Targeting SRSF10 might inhibit M2 macrophage polarization... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun-Xian Du China 11 319 206 70 65 53 22 420
Zuoming Xu China 12 387 1.2× 313 1.5× 73 1.0× 59 0.9× 53 1.0× 20 486
Yongcan Liu China 5 258 0.8× 201 1.0× 51 0.7× 66 1.0× 32 0.6× 9 337
Hongfei Yu China 7 245 0.8× 227 1.1× 39 0.6× 47 0.7× 33 0.6× 11 321
Samaneh Adelian Iran 10 202 0.6× 126 0.6× 45 0.6× 84 1.3× 48 0.9× 13 310
Kaiqing Wu China 4 332 1.0× 208 1.0× 46 0.7× 76 1.2× 47 0.9× 4 399
Shijia Yan China 7 250 0.8× 150 0.7× 71 1.0× 66 1.0× 36 0.7× 9 348
Ye‐Lin Liang China 12 410 1.3× 304 1.5× 78 1.1× 104 1.6× 54 1.0× 21 541
Rujuan Bao China 8 257 0.8× 150 0.7× 75 1.1× 92 1.4× 40 0.8× 10 367
Chenhui Cao China 9 307 1.0× 248 1.2× 39 0.6× 43 0.7× 21 0.4× 15 364
Shaorui Gu China 10 425 1.3× 271 1.3× 55 0.8× 84 1.3× 66 1.2× 16 527

Countries citing papers authored by Jun-Xian Du

Since Specialization
Citations

This map shows the geographic impact of Jun-Xian Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Xian Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Xian Du more than expected).

Fields of papers citing papers by Jun-Xian Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Xian Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Xian Du. The network helps show where Jun-Xian Du may publish in the future.

Co-authorship network of co-authors of Jun-Xian Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-Xian Du. A scholar is included among the top collaborators of Jun-Xian Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-Xian Du. Jun-Xian Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Lipeng, Jun-Xian Du, Yi Shuang, et al.. (2025). Investigation of Surface Flashover Mechanisms in SF 6 /N 2 Mixtures Under Nanosecond Pulse. IEEE Transactions on Dielectrics and Electrical Insulation. 32(6). 3462–3471.
3.
Du, Jun-Xian, Haiyu Wang, Lei Shen, et al.. (2025). KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair. Oncogene. 44(44). 4254–4270. 1 indexed citations
4.
Cai, Jialiang, Peiling Zhang, Gui‐Qi Zhu, et al.. (2025). Lactylation‐Driven NUPR1 Promotes Immunosuppression of Tumor‐Infiltrating Macrophages in Hepatocellular Carcinoma. Advanced Science. 12(20). e2413095–e2413095. 13 indexed citations
5.
Chen, Shiping, Peiling Zhang, Gui‐Qi Zhu, et al.. (2024). Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma. Cellular and Molecular Immunology. 21(12). 1505–1521. 14 indexed citations
6.
Zhang, Feng, Suiyi Wu, Gui‐Qi Zhu, et al.. (2024). Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma. Cancer Communications. 44(11). 1231–1260. 71 indexed citations breakdown →
7.
Geng, Zihan, Jun-Xian Du, Pei‐Yao Fu, et al.. (2024). YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance. Cancer Cell International. 24(1). 71–71. 8 indexed citations
8.
Zhong, Lipeng, Jun-Xian Du, Feng Wang, et al.. (2023). Multi-material and parameter-controllable stereolithography 3D printing of graded permittivity composites for high voltage insulators. Virtual and Physical Prototyping. 18(1). 6 indexed citations
9.
Zhong, Lipeng, Nian Tang, Feng Wang, et al.. (2023). Solid Product Analysis on the Epoxy Resin Surface After Flashovers in C4F7N-Based Gas Mixtures Under Negative DC Voltage. IEEE Transactions on Dielectrics and Electrical Insulation. 31(1). 246–253. 1 indexed citations
10.
Zhu, Guiqi, Yi Wang, Wei‐Ren Liu, et al.. (2022). Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 13(5). 1413–1447. 29 indexed citations
11.
Chen, Shiping, Gui‐Qi Zhu, Xiaoxia Xing, et al.. (2022). LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation Under Hypoxia. Frontiers in Oncology. 12. 882372–882372. 11 indexed citations
12.
Du, Jun-Xian, Yihong Luo, Sijia Zhang, et al.. (2021). Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. Journal of Experimental & Clinical Cancer Research. 40(1). 171–171. 66 indexed citations
13.
Du, Jun-Xian, et al.. (2021). Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021. Chinese Medical Journal. 134(19). 2272–2274. 1 indexed citations
14.
Zhan, Yanxia, Jun-Xian Du, Zhihui Min, et al.. (2021). Carcinoma-associated fibroblasts derived exosomes modulate breast cancer cell stemness through exonic circHIF1A by miR-580-5p in hypoxic stress. Cell Death Discovery. 7(1). 141–141. 65 indexed citations
15.
Du, Jun-Xian, Gui‐Qi Zhu, Yihong Luo, et al.. (2021). Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data. Annals of Translational Medicine. 9(1). 58–58. 4 indexed citations
16.
Du, Jun-Xian, et al.. (2021). A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008). Chinese Medical Journal. 134(18). 2186–2195. 5 indexed citations
17.
Du, Jun-Xian, Gui‐Qi Zhu, Jialiang Cai, et al.. (2020). Splicing factors: Insights into their regulatory network in alternative splicing in cancer. Cancer Letters. 501. 83–104. 33 indexed citations
18.
Du, Jun-Xian, Yihong Luo, Jialiang Cai, et al.. (2020). Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer. Gene. 762. 144974–144974. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026